...ications are not yet reliable enough for clinical decision making. In this context, two innovative EU companies, Optoi Microelectronics - with microelectronic knowhow and manufacturing skills - and DestiNA Genomics - with ‘error free’ chemical technology for microRNAs recognition – joined forces with three key academic research groups from the Universities of Trento (Italy), Granada (Spain) and Sa ...